Key
The 1st Hourly
Math 1107
Summer Term 2007
Protocol
You will use only the
following resources: Your individual calculator; individual tool-sheet (single
8.5 by 11 inch sheet); your writing utensils; blank paper (provided by me) and
this copy of the hourly. Do not share these resources with anyone else.
In each case, show complete
detail and work for full credit. Follow case study solutions and sample hourly
keys in presenting your solutions. Work all six cases. Using only one side of
the blank sheets provided, present your work. Do not write on both sides of the
sheets provided, and present your work only on these sheets. All of your work
goes on one side each of the blank sheets provided. Space out your work. Do not
share information with any other students during this hourly. Sign and
Acknowledge:
I agree to follow this
protocol.
______________________________________________________________________________________
Name (PRINTED)
Signature Date
Case One
Pair of Dice
Random Variable
25 Points Maximum
We have a pair of dice – a fair d3
{faces 1, 3, 5} and a loaded d4 {faces 2, 4, 6, 7} – note the probability
model for the d4 below.
Face |
Probability |
2 |
0.40 |
4 |
0.25 |
6 |
0.25 |
7 |
0.10 |
Total |
1.00 |
We assume that the dice operate separately and
independently of each other. Suppose that our experiment consists of tossing
the dice, and noting the resulting face-pair.
1. List the possible pairs of face values,
and compute a probability for each pair of face values.
25 Points Maximum
15 Points Maximum
(d4,d3) |
2 |
4 |
6 |
7 |
1 |
(2,1) |
(4,1) |
(6,1) |
(7,1) |
3 |
(2,3) |
(4,3) |
(6,3) |
(7,3) |
5 |
(2,5) |
(4,5) |
(6,5) |
(7,5) |
The pairs are: (2,1), (4,1), (6,1), (7,1),
(2,3), (4,3), (6,3), (7,3), (2,5), (4,5), (6,5) and (7,5).
Pr{(2,1)} = Pr{2 from d4}*Pr{1 from d3} = (4/10)*(1/3)
= 4/30 = 16/120
Pr{(2,3)} = Pr{2 from d4}*Pr{3 from d3} = (4/10)*(1/3)
= 4/30 = 16/120
Pr{(2,5)} = Pr{2 from d4}*Pr{5 from d3} = (4/10)*(1/3)
= 4/30 = 16/120 [subtotal = 48/120]
Pr{(4,1)} =
Pr{4 from d4}*Pr{1 from d3} = (1/4)*(1/3) = 1/12 = 10/120
Pr{(4,3)} =
Pr{4 from d4}*Pr{3 from d3} = (1/4)*(1/3) = 1/12 = 10/120
Pr{(4,5)} =
Pr{4 from d4}*Pr{5 from d3} = (1/4)*(1/3) = 1/12 = 10/120 [subtotal = 30/120]
Pr{(6,1)} =
Pr{6 from d4}*Pr{1 from d3} = (1/4)*(1/3) = 1/12 = 10/120
Pr{(6,3)} =
Pr{6 from d4}*Pr{3 from d3} = (1/4)*(1/3) = 1/12 = 10/120
Pr{(6,5)} =
Pr{6 from d4}*Pr{5 from d3} = (1/4)*(1/3) = 1/12 = 10/120 [subtotal = 30/120]
Pr{(7,1)} =
Pr{7 from d4}*Pr{1 from d3} = (1/10)*(1/3) = 1/30 = 4/120
Pr{(7,3)} =
Pr{7 from d4}*Pr{3 from d3} = (1/10)*(1/3) = 1/30 = 4/120
Pr{(7,5)} =
Pr{7 from d4}*Pr{5 from d3} = (1/10)*(1/3) = 1/30 = 4/120 [subtotal = 12/120]
Check: (48/120)+(30/120)+(30/120)+(12/120)
= (78+42)/120 = 120/120 = 1
2. When both faces in the pair are odd, define THING as the product
of the face values in the pair. When exactly one face in the pair is odd,
define THING as the sum of the face values in the pair. Compute and list the
possible values for the variable THING, and compute a probability for each
value of THING.
Show all work and full detail for full
credit.
10 Points Maximum
(d4,d3) |
2 |
4 |
6 |
7 |
1 |
(2,1) One Odd Face: THING = (2+1) = 3 |
(4,1) One Odd Face: THING = (4+1) = 5 |
(6,1) One Odd Face: THING = (6+1) = 7 |
(7,1) Both Faces Odd: THING = 7*1=7 |
3 |
(2,3) One Odd Face: THING = (2+3) = 5 |
(4,3) One Odd Face: THING = (4+3) = 7 |
(6,3) One Odd Face: THING = (6+3) = 9 |
(7,3) Both Faces Odd: THING = 7*3=21 |
5 |
(2,5) One Odd Face: THING = (2+5) = 7 |
(4,5) One Odd Face: THING = (4+5) = 9 |
(6,5) One Odd Face: THING = (6+5) = 11 |
(7,5) Both Faces Odd: THING = 7*5=35 |
The pairs are: (2,1), (4,1), (6,1), (7,1),
(2,3), (4,3), (6,3), (7,3), (2,5), (4,5), (6,5) and (7,5).
THING{(2,1)} = 2
+ 1 = 3
THING{(2,3)} = 2
+ 3 = 5
THING{(2,5)} = 2
+ 5 = 7
THING{(4,1)} = 4
+ 1 = 5
THING{(4,3)} = 4
+ 3 = 7
THING{(4,5)} = 4
+ 5 = 9
THING{(6,1)} = 6
+ 1 = 7
THING{(6,3)} = 6
+ 3 = 9
THING{(6,5)} = 6
+ 5 = 11
THING{(7,1)} = 7*1
= 7
THING{(7,3)} = 7*3
= 21
THING{(7,5)} = 7*5
= 35
Pr{THING=3} =
Pr{(2,1)} = 4/30 = 16/120
Pr{THING=5} =
Pr{One of (2,3), (4,1) Shows} = Pr{(2,3)} + Pr{(4,1)} = (4/30) + (1/12) =
(16+10)/120 = 26/120
Pr{THING=7} =
Pr{One of (2,5), (4,3), (6,1), (7,1) Shows} = Pr{(2,5)} + Pr{(4,3)} + Pr{(6,1)}
+ Pr{(7,1)} =
(16/120) +
(10/120) + (10/120) + (4/120) = 40/120
Pr{THING=9} =
Pr{One of (4,5), (6,3) Shows} = Pr{(4,5)} + Pr{(6,3)} = (10/120) + (10/120) = 20/120
Pr{THING=11} =
Pr{(6,5)} = 10/120
Pr{THING=21} =
Pr{(7,3)} = 4/120
Pr{THING=35} =
Pr{(7,5)} = 4/120
Check: (16/120)
+ (26/120) + (40/120) + (20/120) + (10/120) + (4/120) + (4/120) = (42 + 60 + 18)/120
= (120)/120 =1
Case Two
Color Slot Machine
Conditional Probabilities
25 Points Maximum
Here is our slot machine – on each trial,
it produces a six color sequence, using the table below:
Sequence* |
Probability |
BGBYYG |
0.10 |
GBBRRG |
0.15 |
YRBGGR |
0.11 |
YRGGBB |
0.35 |
YBYYRR |
0.23 |
BBYYRY |
0.05 |
BBBBBY |
0.01 |
Total |
1.00 |
*B-Blue, G-Green, R-Red, Y-Yellow, Sequence is numbered as 1st
to 6th , from left to right: (1st 2nd 3rd
4th 5th6th )
Compute the
following conditional probabilities.
1. Pr{“BB”
Shows | Red Shows}
9 Points Maximum
Sequence* |
Probability |
GBBRRG |
0.15 |
YRBGGR |
0.11 |
YRGGBB |
0.35 |
YBYYRR |
0.23 |
BBYYRY |
0.05 |
Total |
0.89 |
Pr{Red Shows} = Pr{One of GBBRRG, YRBGGR, YRGGBB,
YBYYRR, BBYYRY Shows} =
Pr{GBBRRG} + Pr{YRBGGR} + Pr{YRGGBB} + Pr{YBYYRR}
+ Pr{BBYYRY} =
0.15 + 0.11 + 0.35 + 0.23 + 0.05 = 0.89
Sequence* |
Probability |
GBBRRG |
0.15 |
YRGGBB |
0.35 |
BBYYRY |
0.05 |
Total |
0.55 |
Pr{“BB” and Red Show} = Pr{One of GBBRRG, YRGGBB,
BBYYRY Shows} =
Pr{GBBRRG} + Pr{YRGGBB} + Pr{BBYYRY} = 0.15
+ 0.35 + 0.05 = 0.55
Pr{“BB” Shows | Red Shows} = Pr{“BB” and Red
Show}/ Pr{Red Shows} = 0.55/0.89
2. Pr{Red
Shows | “BY” Shows }
8 Points Maximum
Sequence* |
Probability |
BGBYYG |
0.10 |
YBYYRR |
0.23 |
BBYYRY |
0.05 |
BBBBBY |
0.01 |
Total |
0.39 |
Pr{“BY” Shows} = Pr{One of BGBYYG, YBYYRR, BBYYRY, BBBBBY Shows} =
Pr{BGBYYG} + Pr{YBYYRR} + Pr{BBYYRY} + Pr{BBBBBY}
=
0.10 + 0.23 + 0.05 + 0.01 = 0.39
Sequence* |
Probability |
YBYYRR |
0.23 |
BBYYRY |
0.05 |
Total |
0.28 |
Pr{“BY” and Red Show} = Pr{One of YBYYRR, BBYYRY Shows} =
Pr{YBYYRR} + Pr{BBYYRY} = 0.23 + 0.05 = 0.28
Pr{Red Shows | “BY” Shows} = Pr{“BY” and Red
Show}/ Pr{“BY” Shows} = 0.28/0.39
3. Pr{Green
Shows | Red Shows}
9 Points Maximum
Sequence* |
Probability |
GBBRRG |
0.15 |
YRBGGR |
0.11 |
YRGGBB |
0.35 |
YBYYRR |
0.23 |
BBYYRY |
0.05 |
Total |
0.89 |
Pr{Red Shows} = Pr{One of GBBRRG, YRBGGR, YRGGBB,
YBYYRR, BBYYRY Shows} =
Pr{GBBRRG} + Pr{YRBGGR} + Pr{YRGGBB} + Pr{YBYYRR}
+ Pr{BBYYRY} =
0.15 + 0.11 + 0.35 + 0.23 + 0.05 = 0.89
Sequence* |
Probability |
GBBRRG |
0.15 |
YRBGGR |
0.11 |
YRGGBB |
0.35 |
Total |
0.61 |
Pr{Green and Red Show} = Pr{One of GBBRRG, YRBGGR,
YRGGBB Shows} =
Pr{GBBRRG} + Pr{YRBGGR} + Pr{YRGGBB} = 0.15
+ 0.11 + 0.35 = 0.61
Pr{Green Shows | Red Shows} = Pr{Green and Red
Show}/ Pr{Red Shows} = 0.61/0.89
Show all work and full detail for full
credit.
Case Three
Long Run Argument and Perfect Samples
Traumatic Brain Injury (TBI) and Glasgow Coma Scale
(GCS)
25 Points Maximum
Traumatic brain injury (TBI) is an insult to the brain from an external mechanical
force, possibly leading to permanent or temporary impairments of cognitive,
physical, and psychosocial functions with an associated diminished or altered
state of consciousness. The Glasgow Coma
Scale (GCS) is the most widely used system for scoring the level of
consciousness of a patient who has had a traumatic brain injury. GCS is based
on the patient's best eye-opening, verbal, and motor responses. Each response
is scored and then the sum of the three scores is computed. The total score
varies from 3 to 15. The GCS categories are Mild (for GCS scores between 13 and 15), Moderate (for GCS scores between 9 and 12) and Severe (for GCS scores between 3 and 8). It is not unusual for
people to die with TBI before they can be treated or evaluated. We can augment
the GCS categories by adding a PAD
(Pre-admission Death, TBI Noted) category. Suppose that the probabilities
tabled below apply to TBI cases:
TBI
Severity |
Probability |
Mild |
0.10 |
Moderate |
0.15 |
Severe |
0.50 |
PAD |
0.25 |
Total |
1.00 |
1. Interpret
each probability using the Long Run Argument.
10 Points Maximum
In long runs of sampling with replacement,
approximately 10% of sampled TBI cases are mild.
In long runs of sampling with replacement,
approximately 15% of sampled TBI cases are moderate.
In long runs of sampling with replacement,
approximately 50% of sampled TBI cases are severe.
In long runs of sampling with replacement,
approximately 25% of sampled TBI cases are pre-admission deaths(PAD).
2. Compute
and discuss Perfect Samples for n=1200.
15 Points Maximum
9 Points Maximum
EMild = 1200*PMild =
1200*0.10 = 120
EModerate = 1200*PModerate
= 1200*0.15 = 180
ESevere = 1200*PSevere
= 1200*0.50 = 600
EPAD = 1200*PPAD =
1200*0.25 = 300
Check: EMild + EModerate
+ ESevere + EPAD = 120 + 180 + 600 + 300 = 1200
6 Points Maximum
Random samples of TBI cases of size 1200
yield approximately 120 mild cases.
Random samples of TBI cases of size 1200
yield approximately 180 moderate cases.
Random samples of TBI cases of size 1200
yield approximately 600 severe cases.
Random samples of TBI cases of size 1200
yield approximately 300 PAD cases.
Show all work and full detail for full
credit. Provide complete discussion for full credit.
Case Four
Color Slot Machine
Probability Rules
25 Points Maximum
Here is our slot machine – on each trial,
it produces a six color sequence, using the table below:
Sequence* |
Probability |
BGBYYG |
0.10 |
GBBRRG |
0.15 |
YRBGGR |
0.11 |
YRGGBB |
0.35 |
YBYYRR |
0.23 |
BBYYRY |
0.05 |
BBBBBY |
0.01 |
Total |
1.00 |
*B-Blue, G-Green, R-Red, Y-Yellow, Sequence is numbered as 1st
to 6th , from left to right: (1st 2nd 3rd
4th 5th6th )
Compute the following probabilities. If a rule is
specified, you must use that rule.
1. Pr{“YR”
Shows }
9 Points Maximum
Sequence* |
Probability |
YRBGGR |
0.11 |
YRGGBB |
0.35 |
YBYYRR |
0.23 |
BBYYRY |
0.05 |
Total |
0.74 |
Pr{“YR” Shows } = Pr{One of YRBGGR, YRGGBB,
YBYYRR, BBYYRY Shows} =
Pr{YRBGGR} + Pr{YRGGBB} + Pr{YBYYRR} + Pr{BBYYRY}
= 0.11 + 0.35 + 0.23 + 0.05 = 0.46 + 0.28 = 0.74
2. Pr{ Green
Shows 2nd or 3rd }
8 Points Maximum
Sequence* |
Probability |
BGBYYG |
0.10 |
YRGGBB |
0.35 |
Total |
0.45 |
Pr{ Green Shows 2nd or 3rd
} = Pr{One of BGBYYG, YRGGBB Shows} =
Pr{BGBYYG} + Pr{YRGGBB} = 0.10 + 0.35 =
0.45
3. Pr{ Green
Shows } – Use the Complementary Rule
8 Points Maximum
Failure to Use CR: 6 points off
Sequence* |
Probability |
BGBYYG |
0.10 |
GBBRRG |
0.15 |
YRBGGR |
0.11 |
YRGGBB |
0.35 |
YBYYRR |
0.23 |
BBYYRY |
0.05 |
BBBBBY |
0.01 |
Total |
1.00 |
Other Event = “Green does not Show”
Pr{Green does not Show} = Pr{YBYYRR} + Pr{BBYYRY}
+ Pr{BBBBBY} = 0.23 + 0.05 + 0.01 = 0.29
Pr{Green Shows} = 1 – Pr{Green does not
Show} = 1 – 0.29 = 0.71
Check:
Pr{Green Shows} = Pr{One of BGBYYG, GBBRRG,
YRBGGR, YRGGBB Shows} =
Pr{BGBYYG} + Pr{GBBRRG} + Pr{YRBGGR} + Pr{YRGGBB}
=
0.10 + 0.15 + 0.11 + 0.35 = 0.25 + 0.46 =
0.71
Show all work and full detail for full
credit.
Case Five
Design Fault Spot
25 Points Maximum
In each of the following a brief description of a
design is presented. Briefly identify faults present in the design. Use the
information provided. Be brief and complete.
1. A sample
of college students is needed for a sample survey. The people running the study
decide on the
following: they divide the
population of colleges and universities into groups based upon enrollment size
and whether the college or university is private or public; next, they used
judgment to select one school from each group. Then, a random sample of
students was selected from each selected school.
7 Points Maximum
The first stage of sampling is non-random.
Both stages of sampling should be random.
2. In a
comparative clinical trial, treatment methods are compared in the treatment of
Condition Z, which when left untreated leads to severe complications and
possibly death. Suppose we have a new candidate treatment, and further suppose
that a standard treatment for a similar (but different) disease is available. A
comparative clinical trial is proposed that would compare these treatments in
patients with condition Z.
6 Points Maximum
The new treatment is not necessarily
appropriate for Condition Z.
3. In a
comparative clinical trial, treatment methods are compared in the treatment of
Condition X, which when left untreated leads to severe complications and
possibly death. A new surgical method is compared to a standard surgical
method. Study physicians classify subjects by the severity of their disease,
and assign only the "moderate" subjects to the new surgical method.
Only the "severe" subjects are assigned to the standard surgical
method.
6 Points Maximum
Patients must be randomly assigned to treatment.
4. Sample survey
planning is under way to study voter support levels for a proposed (federal)
constitutional amendment. The proposal is to randomly sample US resident
adults, aged 18 years or older.
6 Points Maximum
The survey should target registered or
likely voters. Many adults rarely or never vote, and even registered voters
might choose to not vote.
Case Six
Clinical Trial Sketch
Behcet’s Syndrome
25 Points Maximum
Inflammation
is the body’s response to irritation, infection, injury or other insults.
Inflammation is mediated by the immune system, and includes redness, heat,
swelling and pain. Behcet’s sndrome
is a medical condition in which the patient suffers chronic inflammation of
blood vessels. Patients with Behcet’s syndrome suffer complications when organs
are affected by inflammatory flare-ups. One source of complications is uveitis (inflammation of the uvea (which
includes the iris)). In some cases, complications of Behcet’s-induced uveitis
can threaten vision. A similar condition, retinitis,
affects the retina. Vision may be threatened by certain forms of uveitis and
retinitis.
|
The uvea is the pigmented,
middle lining of the eye. The term derives from the Latin word for grape,
because the uvea can resemble the outer skin of a grape. The uvea includes
the iris up front and includes the ciliary body and choroid in back. The uvea
lies behind the retina. The symptoms of Behcet's
syndrome are usually treated with corticosteroids to suppress inflammation.
Other medicines such as methotrexate, cyclophosphamide, or azathioprine may
also be used. These drugs all can have serious side effects, including liver
or kidney damage. As a result, some patients forego treatment with these
medications. |
Repeated inflammatory attacks
can damage the uvea and/or retina. Accumulated damage can affect, impair and
ultimately cause vision loss. The standard treatment is the use of
anti-inflammatories, such as cortico-steroids, which treat inflammation.
Successful response to these treatments includes fewer attacks, attacks of
shorter duration and less severe attacks. Ultimately, the objective is the
preservation of sight.
Other treatments attempt to
prevent inflammation. Zenapax is an immuno-suppressive drug that basically
blocks the signaling of lymphocytes by locking IL-2 receptors on the
lymphocytes. As a result, the blocked lymphocytes do not initiate inflammatory
processes. In this trial, we focus on patients with Behcet’s syndrome. More
specifically, we focus on those patients with uveitis/retinitis and whose
vision is threatened.
Sketch a comparative clinical trial
comparing the effect of Anti-inflammatories versus Anti-inflammatories +
Zenapax in the treatment of Behcet’s syndrome with vision-threatening
uveitis/retinitis.
Make your sketch concise
and complete, following the style demonstrated in class, in the sample second
hourlies and in case study summaries.
We seek to recruit adult human subjects with Behcet’s syndrome with vision-threatening
uveitis/retinitis. We inform potential study
volunteers of the potential risks and benefits of study participation, as
well as the details of the study protocol. Those who qualify and volunteer under informed consent are
then enrolled in the study. Enrolled subjects present Behcet’s syndrome with
vision-threatening uveitis or retinitis. The standard treatment is an anti-inflammatory regime plus a placebo version of Zenapax. The candidate treatment is an anti-inflammatory regime
plus Zenapax. Subjects are randomly
assigned to either the standard or the candidate treatement protocol. Double-blinding is employed, so that
neither the subjects nor the clinical personnel know the individual treatment
assignments.
Treated subjects
are then followed for safety outcomes,
including routine or minor side effects. Treated subjects are followed for toxic events, including kidney/liver
damage, organ failure and the like. Treated subjects are followed for treatment response, including
frequency, duration and severity of inflammatory flare-ups in the uvea and/or
retina, as well as visual acuity and preservation of sight.
Work all six (6) cases.